NEW YORK: Texas’s top prosecutor on Wednesday announced the state had reached a US$41.5 million settlement with US drugmakers Pfizer and Tris Pharma over allegations of drug adulteration and defrauding the state’s Medicaid programme.
The settlement resolves a 2023 lawsuit that accused the pharmaceutical companies of manipulating quality control tests of a medication used to treat Attention Deficit Hyperactivity Disorder (ADHD), according to a statement from Ken Paxton, the southern US state’s Republican attorney general.
Under the settlement, Pfizer expressly denies “any and all liability and wrongdoing,” the New York City-based company said in a statement Wednesday.